{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:06:42Z","timestamp":1784552802687,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jneuroim.2026.578946","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:03Z","timestamp":1776898983000},"page":"578946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MicroRNA profiles in multiple sclerosis: A review of the literature"],"prefix":"10.1016","volume":"417","author":[{"given":"Andreea","family":"Ple\u0219a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"M\u0103run\u021belu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavian Mihai","family":"S\u00eerbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru Andrei","family":"Badea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentina Cristina","family":"Ple\u0219a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Adella","family":"S\u00eerbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"Antochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.578946_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106648","article-title":"Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis","volume":"200","author":"Agostini","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578946_bb0010","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/1352458515613641","article-title":"Deregulation of microrna-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis","volume":"22","author":"Ahlbrecht","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12970","article-title":"Microrna-155 influences b-cell function through PU.1 in rheumatoid arthritis","volume":"7","author":"Alivernini","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2024.104903","article-title":"Analysis of potential microRNA biomarkers for multiple sclerosis","volume":"137","author":"Al-Temaimi","year":"2024","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578946_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/TP.0b013e3181e913c2","article-title":"MicroRNAs: small RNAs with big effects","volume":"90","author":"Anglicheau","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578946_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-017-1006-3","article-title":"Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS","volume":"14","author":"Bruinsma","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578946_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrrheum.2014.19","article-title":"Emerging role of extracellular vesicles in inflammatory diseases","volume":"10","author":"Buz\u00e1s","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578946_bb0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2009.01.008","article-title":"MicroRNAs: novel regulators of immunity","volume":"8","author":"Carissimi","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"5654","key":"10.1016\/j.jneuroim.2026.578946_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"Micrornas modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578946_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031664","article-title":"Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis: disease-stage specificity and relevance to pathophysiology","volume":"23","author":"Cuomo-Haymour","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578946_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10449-0","article-title":"Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4\/MyD88 pathway","volume":"7","author":"Dalvi","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578946_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12765","article-title":"MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis","volume":"48","author":"De Vito","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578946_bb0065","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578145","article-title":"Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial","volume":"381","author":"Elkjaer","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"18","key":"10.1016\/j.jneuroim.2026.578946_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814192","article-title":"Antibody content against Epstein-Barr virus in blood extracellular vesicles correlates with disease activity and brain volume in patients with relapsing-remitting multiple sclerosis","volume":"24","author":"Fern\u00e1ndez-Fournier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578946_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030679","article-title":"The majority of microRNAs detectable in serum and saliva is concentrated in exosomes","volume":"7","author":"Gallo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jneuroim.2026.578946_bb0085","first-page":"92","article-title":"Microrna in multiple sclerosis","volume":"516","author":"Gao","year":"2021","journal-title":"Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578946_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-023-02816-8","article-title":"Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study","volume":"20","author":"Gonzalez-Martinez","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578946_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2199-11-67","article-title":"The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site","volume":"11","author":"Guillon-Munos","year":"2010","journal-title":"BMC Mol. Biol."},{"issue":"22","key":"10.1016\/j.jneuroim.2026.578946_bb0100","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1212\/WNL.0b013e3182759621","article-title":"Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study","volume":"79","author":"Haghikia","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578946_bb0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tins.2018.03.006","article-title":"Extracellular vesicles: multimodal envoys in neural maintenance and repair","volume":"41","author":"Holm","year":"2018","journal-title":"Trends Neurosci."},{"issue":"83","key":"10.1016\/j.jneuroim.2026.578946_bb0110","article-title":"The relationship between TIGIT+ regulatory t cells and autoimmune disease","volume":"32172208","author":"Jun","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578946_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007440","article-title":"Multiple sclerosis: microrna expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls","volume":"4","author":"Keller","year":"2009","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578946_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12185-010-0633-6","article-title":"MiRNAs in normal and malignant b cells","volume":"92","author":"Kotani","year":"2010","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578946_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000623","article-title":"Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: a validation study","volume":"6","author":"Kramer","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578946_bb0130","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI94012","article-title":"MiR-146a modulates autoreactive th17 cell differentiation and regulates organ-specific autoimmunity","volume":"127","author":"Li","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578946_bb0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/00207454.2012.678444","article-title":"MiR-15a and 16-1 are downregulated in CD4+ t cells of multiple sclerosis relapsing patients","volume":"122","author":"Lorenzi","year":"2012","journal-title":"Int. J. Neurosci."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578946_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094332","article-title":"miR-155 as an important regulator of multiple sclerosis pathogenesis. A review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12967-015-0504-2","article-title":"MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression","volume":"13","author":"Mancuso","year":"2015","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578946_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020330","article-title":"The microrna let-7b-5p is negatively associated with inflammation and disease severity in multiple sclerosis","volume":"10","author":"Mandolesi","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578946_bb0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4103\/1673-5374.266905","article-title":"MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression","volume":"15","author":"Martinez","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/897249","article-title":"Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ t cells of patients with relapsing-remitting multiple sclerosis","volume":"2014","author":"Meira","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pharmthera.2018.08.002","article-title":"Extracellular vesicles and their nucleic acids for biomarker discovery","volume":"192","author":"Momen-Heravi","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578946_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200069","article-title":"MiRNA signature in CSF from patients with primary progressive multiple sclerosis","volume":"10","author":"Mu\u00f1oz-San Mart\u00edn","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578946_bb0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/1352458519879303","article-title":"MicroRNA and exosome profiling in multiple sclerosis","volume":"26","author":"Mycko","year":"2020","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578946_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006309","article-title":"Differential micro RNA expression in PBMC from multiple sclerosis patients","volume":"4","author":"Otaegui","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jneuroim.2026.578946_bb0185","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2026.578946_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2019.04.002","article-title":"Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: a comprehensive overview","volume":"101","author":"Piket","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578946_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001874","article-title":"Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation","volume":"12","author":"Ridder","year":"2014","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578946_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040851","article-title":"Targeting and crossing the blood-brain barrier with extracellular vesicles","volume":"9","author":"Saint-Pol","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578946_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clim.2012.04.002","article-title":"Altered microRNA expression in b lymphocytes in multiple sclerosis: towards a better understanding of treatment effects","volume":"144","author":"Sievers","year":"2012","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578946_bb0215","first-page":"1567","article-title":"Mir-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis","volume":"189","author":"Smith","year":"2012","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.jneuroim.2026.578946_bb0220","article-title":"Pregnancy-induced changes in microRNA expression in multiple sclerosis","volume":"11","author":"S\u00f8ndergaard","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2023.06.025","article-title":"Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in multiple sclerosis","volume":"113","author":"Torres Iglesias","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1224217","article-title":"Dual role of peripheral b cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers","volume":"14","author":"Torres Iglesias","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578946_bb0235","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200420","article-title":"Extracellular vesicle-derived MicroRNAs as a biomarker for therapeutic response in multiple sclerosis","volume":"12","author":"Torres-Iglesias","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578946_bb0240","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters","volume":"132","author":"Ventura","year":"2008","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578946_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024604","article-title":"Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis","volume":"6","author":"Waschbisch","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578946_bb0250","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190812","article-title":"CNS-localized myeloid cells capture living invading t cells during neuroinflammation","volume":"217","author":"Wasser","year":"2020","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578946_bb0255","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/jcbfm.2014.207","article-title":"Brain endothelial miR-146a negatively modulates t-cell adhesion through repressing multiple targets to inhibit NF-\u03baB activation","volume":"35","author":"Wu","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578946_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1226130","article-title":"MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study","volume":"14","author":"Zangh\u00ec","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:54:48Z","timestamp":1784552088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":53,"alternative-id":["S0165572826000949"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578946","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA profiles in multiple sclerosis: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578946"}}